170372 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates; Assays involving proteins of known structure or function as defined in the subgroups; Details Amyloid plaque core protein
Oligomerization of amyloid proteins
#602Screening method for the identification of a drug for the development of an agent for prevention and/or treatment of Alzheimer's disease
#603Methods For Detecting Substances Which Bind To The Amyloid Precursor Protein Or Beta Amyloid Fragments, And Binding Compounds
#604Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
#605Inhibition of tau-tau-association
#606Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
#607Diagnostic method for stroke
#608Monoclonal antibody
#609Fluorescence polarization assay
#610Phosphorylation of tau by abl
#611PHARMACEUTICAL COMPOSITIONS FOR SUPPRESSING B-AMYLOID PRODUCTION
#612Monoclonal antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence
#613Methods for the identification of agents that modulate the structure and processing of beta-amyloid precursor protein
#614Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
#615Angiogenic peptides and uses thereof
#616Gamma secretase notch biomarkers
#617Methods and kits for the detection of prion diseases
#618Compositions and methods for detection and isolation of phosphorylated molecules
#619Method for indentifying modulators of PPIL2 useful for treating Alzheimer's disease
#620Anti-ADDL antibodies and uses thereof
#621NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID
#622Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
#623Methods for modulating transcriptional activation using mint proteins
#624Inhibitors of amyloid precursor protein processing
#625Novel treatment
#626Use of prion conversion modulating agents
#627Diagnostic and therapeutic use of a rab family gtp-binding protein for neurodegenerative diseases
#628Methods, compositions and compound assays for inhibiting amyloid-beta protein production
#629Agglomeration protein cascades, compositions and methods regarding the same
#630Therapeutic agent for Abeta related disorders
#631Method of monitoring immunotherapy
#632Anti-ADDL antibodies and uses thereof
#633Prevention and treatment of amyloid-associated disorders
#634Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
#635Alzheimer's related proteins and methods of use
#636Prediction of Parkinson's disease using gene expression levels of peripheral blood samples
#637N-11 truncated amyloid-beta Aβ11-x monoclonal antibodies and compositions
#638Methods to differentiate protein conformers
#639System and method for providing personalized healthcare for alzheimer's disease
#640Diagnostic and therapeutic use of ensadin-0477 gene and protein for neurodegenerative diseases
#641Methods and compositions for treating Alzheimer's disease
#642Methods for decreasing beta amyloid protein
#643Human brain carboxypeptidase B antibodies
#644Complex of a chaperone with β-amyloid and methods employing this complex
#645Compositions and methods for Alzheimer's disease
#646Modulators of β-amyloid peptide aggregation comprising D-amino acids
#647Inhibition of tau-tau-association
#648Method for differentiation of Alzheimer's Disease into subgroups
#649Monoclonal antibodies directed against the microtubule-associated protein tau and method of detecting the same
#650Methods, compositions and compound assays for inhibiting amyloid-beta protein production
#651Methods, compositions and compound assays for inhibiting amyloid-beta protein production
#652Methods, compositions and compound assays for inhibiting amyloid-beta protein production
#653Novel treatment
#654Purified antigen for Alzheimer's disease and methods of obtaining and using same
#655Method of detecting and preventing Alzheimer's disease, particularly at prodromal and early stages
#656Methods for identifying a compound that inhibits the procession of amyloid-beta protein production in a mammalian cell expressing APP and overexpressing a G-protein coupled receptor in the cell
#657Transgenic mouse whose genome comprises an APP having a mutation at amino acid 664
#658Styryl dyes with linker
#659Reagents and methods for identification of binding agents
#660Antibody specific for mutant presenilin 1
#661Process and apparatus comprising episcopic differential contrast (EDIC) microscopy plus epifluorescence microscopy (EF) for the detection or identification of biological materials on surfaces
#662Compounds for the diagnosis/prevention/treatment of alzheimer's disease
#663Isolated components of dense microspheres derived from mammalian brain tissue and antibodies thereto
#664Methods and compositions comprising non-peptide small molecules that solubilize the alzheimer's Abeta peptide fiber
#665Antibody specific to central nervous system tau protein
#666Methods and compositions relating to modulating amyloid precursor protein cleavage
#667Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of Alzheimer's disease
#668Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
#669Inhibitors of amyloid precursor protein processing
#670Methods of diagnosing or treating Alzheimer's disease on basis of increased cerebrospinal fluid levels of nerve growth factor
#671Antibodies specific for toxic amyloid beta protein oligomers
#672Urine test for the diagnosis of prion diseases
#673Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (X->41) and tau
#674Method for characterizing and separating molecular associates
#675Novel gene nedl-1
#676Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
#677Compositions and methods for diagnosing Alzheimer's disease
#678Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging
#679Compositions and methods for detection and isolation of phosphorylated molecules
#680In vitro detection of prions